1- Qualifications :
- MB. Bch. Nov 1996,Faculty of Medicine Tanta University
- Diploma in Hospital Management, August 2000, Faculty of Commerce, Tanta University
- Master Degree in Radiotherapy (CLINICAL Oncology), Nov 2004, Faculty of Medicine, Cairo University.
- ESMO Member 2008. ECCO Member 2009.
- ASCO Associate member April 1, 2010
2- job experiences
1- House Officer at Menshawy Hospital, Ministry Of Health (1/3/1997 to 28/2/1998).
2- Causality Doctor at Egypt Armed Forces (4/1998 to 6/1999).
3- General Practitioner at primary health care units from 1/6/1999 to 11/2000.
4- Resident In Surgical Oncology Unite In Nasser Institute from 11/2000 to 5/2001.
5- Resident in Medical Hematology-oncology unite Chemotherapy and Radiotherapy Unite in Nasser institute since 5/2001 up to 1-07 (6 years)
6- Assistant manager in Nasser Institute oncology Center and Medical administrator in Nasser Institute since 1/2002 up to 1-07 (5 years)
7- Assistant manager in Alfa Medical Scientific Foundation LTD group (Medical conferences organization) as Part Timer.
8- Resident Adult Medical Oncology and Palliative Care Unit in King Fahad Specialist Hospital –Dammam since 1-07 to 30-6-09
9- Assistant consultant in Adult medical oncology in King Abdelaziz Medical City-NGHA-Riyadh since 1-7-09. To 1/7/17 ( 8 years with awards )
10- Assigned for SRS committee in NGH up to 2017.
11- Shared in Quality project of colon cancer for JCI accreditation NGHA-R
12- Built chemotherapy protocols in Best Care system in NGHA-R
13- Revision of all chemotherapy protocols in Beast care system.
14- Best care system super user.
15- Main member in Tumor Boards in NGHA-R and decision maker
16- Acting Consultant (registrar) in SCM-R (current position since 2/7/17)
17- Co-chairman of oncology department SMC , Chairman of Cancer care committee and MDT , SMC Riyadh
18- Admin member for CEBAHI requirements for oncology department SMC-R with appreciation certificate.
Training Courses and conferences:
1-Family Planning and IUDs Insertion Course
2-Training for Primary health care in March 1998.
3-Computer Skills: Office2003,2007,Win XP,Vista,Win7 Internet,PDF…etc.
4-Applied Radiation Physics and Technology, NCI, Cairo University, 18-23 May, 2002.
5-Tele-Medicine Training Course in Nasser Institute 11/1/2003 to 15/1/2003.
6-2nd NCI-EORTC Lung Cancer Symposium Held in Sharm-Elsheikh, 26-28 February 2003.
7-Participant in the scientific sessions and workshop of the 8th International Conference and 2nd Scientific Week of the General Organization For Teaching Hospital And Institutes, 11-16 October 2003.
8-Attendant and Participant in Annual Cancer Conference of the Egyption Cancer Society , Danish Cancer Society , and Aarhus University Hospital, 9-11 February,2005,Ain Sokhna-Egypt.
9-BLS program.
10- Medica plus training program in King Fahad Specialist Hospital.
11- Basic medication safety course May 16, 2010
12- Palliative and End Of Life Care Workshop (THE EPEC-O Project) October 13-15, 2008, institute for palliative medicine at San Diego Hospice USA. National Guard Hospital, Riyadh.
13- EPEC-O Professional course, education in palliative and end of life care 11th-12th of May 2010, NGHA-R
14- Wyeth investigators meeting for Neratinib study 3004, 3005, Hilton Vienna, Austria 18-20 November, 2009.
15- 2010 ASCO annual meeting attendance June 4-8, 2010, 2014
16- 33rd annual CTRC-AACR SAN-ANTONIO breast cancer symposium ,Texas December 8-12, 2010, 2013
17- BEAST OF SAN ANTONIO 2015 attendant
18- Attendance and speaker in Cancer Prevention and Early detection, Riyadh, 22nd to 23rd of December 2010.
19- speaker in Best of San Antonio annual meeting 2018 Almadina KSA.
20- BMS, Lilly, Pfizer, Roche consultancy advisor.
21- Novartis annual meeting speaker 2015 Jeddah .
Researches publications and ongoing Researches:
1-Master Thesis Titled: Neuroblastoma Evaluation of Treatment Outcomes of Various Therapeutic Approaches in NEMROCK from1990 till 2000.
2- Investigator Memmber in NGHA-Riyadh (REALME, LUNG CANCER DATA BASE, co-investigator in Niratinib study 3004, 3005, Retrospective study brain mets in breast cancer patients,…………………………………………………
3- Delayed Paclitaxel- Trastuzumab-Induced Interstitial Pneumonitis in
Breast Cancer , Case Rep Oncol 2011;4:186–191 DOI: 10.1159/000326063 © 2011 S. Karger AG, Basel ISSN 1662–6575
www.karger.com/cro,Omalkhair Abulkhair, Wael El Melouk
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC308078...
Link http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=80051
http://www.eurekaselect.com/139616/article
https://www.researchgate.net/publication/313949517...
7-Approved booster in NCI oncology meeting Egypt from 4-7th Nov 2018
8- co investigator in “A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastatic Triple-Negative Breast Cancer (TNBC)” started 11/19 in SMC hospital (ongoing )
9- Co-investigator (Treatment patterns and clinical outcomes among patients receiving palbociclib combinations for hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) advanced/metastatic breast cancer in the Arabian Gulf Region like Saudi Arabia, UAE and other GCC countries: A retrospective study (Treasure Study) will start soon in 7/2020
10 -Board Member MDT :
1-HCC, GIT, THORACIC, HEAD&NECK, BREAST, RCC, TUMOR BOARDS In National Guard Hospital Riyadh, speaker and attendant.
2-BREAST CANCER TUMOR BOARD with MD ANDERSON center, VIDEO CONFERENCE, speaker and attendant.
3-GI/Sarcoma Video Conference Meeting with American University of Beirut & Memorial Sloan Kettering Cancer Center, New York, speaker and attendant.
4-Co-chairman member in Tumor board meeting in SMC Riyadh since 7/2017
certificates